Darmstadt, Germany

Rainer Klink

This inventor holds 3 USPTO granted patents. Top assignee: Merck Patent Gesellschaft MIT Beschrankter Haftung. Active years: 1978-1989.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 1978-1989

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Rainer Klink: Innovator in Enzymatic Determination

Introduction

Rainer Klink is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of enzymatic analysis, particularly in the determination of alpha-amylase. With a total of 3 patents to his name, Klink's work has advanced the methodologies used in biochemical testing.

Latest Patents

Klink's latest patents focus on processes and reagents for the determination of alpha-amylase. One of his notable inventions involves an enzymatic splitting of an alpha-amylase substrate in the presence of alpha-glucosidase and beta-glucosidase, followed by the measurement of a fission product. The substrate utilized in this process is a 4-nitrophenyl-beta,D-maltoheptaoside, which is electronegatively substituted in the phenyl nucleus. This innovative approach enhances the accuracy and efficiency of alpha-amylase determination.

Career Highlights

Rainer Klink is associated with Merck Patent Gesellschaft mit beschränkter Haftung, where he has been instrumental in developing new analytical techniques. His expertise in enzymatic processes has positioned him as a key figure in the field of biochemistry.

Collaborations

Klink has collaborated with notable colleagues such as Eberhard Henkel and Barkew Dolabdjian. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Rainer Klink's contributions to the field of enzymatic determination reflect his dedication to advancing scientific knowledge. His patents and collaborations continue to influence the methodologies used in biochemical analysis today.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…